Intravascular bioresorbable polymeric stents: A potential alternative to current drug eluting metal stents

Journal of Pharmaceutical Sciences

Volumn 96, Issue 11, 2007, Pages 2829-2837

  Sharkawi, Tahmer ^a,b   Cornhill, Frederick ^c   Lafont, Antoine ^d   Sabaria, Patrick ^b   Vert, Michel ^a  

^a UNIV MONTPELLIER   (France)

^b Arterial Remodelling Technologies   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d INSERM   (France)

Author keywords

Bioresorbable polymeric stent; Coronary artery disease; Drug eluting stent; Local drug delivery; Poly(lactic acid)

Indexed keywords

POLYMER;

ANGIOPLASTY; CORONARY ARTERY DISEASE; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; ELASTICITY; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; SHORT SURVEY;

EID: 36849008192     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20957     Document Type: Short Survey

References (51)

1. Peterson S, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A. 2005. European cardiovascular disease statistics 2005 edition. Brussels: European Union. p 100.
2. Dotter CT, Judkins MP. 1964. Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application. Circulation 30:654-670.
3. Gruntzig A. 1978. Transluminal dilatation of coronary-artery stenosis. Lancet 1:263.
4. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R. 2002. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780.
5. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerekens U, Russell ME. 2003. TAXUS I: Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107:38-42.
6. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT. 2005. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45:2088-2092.
7. Henderson D, Gunalingam B. 2006. Very late stent thrombosis of a sirolimus-eluting stent. Catheter Cardiovasc Interv 68:406-408.
8. Lee CH, Lim J, Low A, Tan HC, Lim YT. 2006. Late angiographic stent thrombosis of polymer based paclitaxel eluting. Heart 92:551-553.
9. Colombo A, Karvouni E. 2000. Biodegradable stents: "Fulfilling the mission and stepping away". Circulation 102:371-373.
10. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM. 1995. Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res 76:996-1002.
11. Lafont A, Moreyra C, Grati Z, Durand E, Bougrini K, Rahal S, Desnos M, Guerot C. 1997. Elargissement compensateur versus constriction chronique. Les 2 modalites du remodelage vasculaire apres angioplastie experimentale. Arch Mal Coeur Vaiss 90:827-834.
12. Griffiths h, Peeters P, Verbist J, Bosiers M, Deloose K, Heublein B, Rohde R, Kasese V, Ilsley C, Di Mario C. 2004. Future devices: Bioabsorbable stents. Br J Cardiol (Acute Interv Cardiol) 11:AIC 80-AIC 84.
13. Barth KH, Virmani R, Froelich J, Takeda T, Lossef SV, Newsome J. 1996. Paired comparison of vascular wall reactions to Palmaz stents. Strecker Circulation 93:2161-2169.
14. Murphy JG, Schwartz RS, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR Jr. 1992. Percutaneous polymeric stents in porcine coronary arteries. Initial experience with polyethylene terephthalate stents. Circulation 86:1596-1604.
15. van der Giessen WJ, Slager CJ, van Beusekom HM, van Ingen Schenau DS, Huijts RA, Schuurbiers JC, de Klein WJ, Serruys PW, Verdouw PD. 1992. Development of a polymer endovascular prosthesis and its implantation in porcine arteries. J Interv Cardiol 5:175-185.
16. Bosiers M, Deloose K, Verbist J, Peeters P. 2006. Will absorbable metal stent technology change our practice? J Cardiovasc Surg (Torino) 47:393-397.
17. Eberhart RC, Su SH, Nguyen KT, Zilberman M, Tang L, Nelson KD, Frenkel P. 2003. Bioresorbable polymeric stents: Current status and future promise. J Biomater Sci Polym Ed 14:299-312.
18. Vert M. 2004. Poly(lactic acid)s. In: Doi Y, editor. Encyclopedia of biomaterials and biomedical engineering. 1st edition. New York: Marcel Dekker, Inc., New York. pp 1254-1263.
19. Brannon-Pepas L, Vert M. 2000. Polylactic acid and polyglycolic acids as drug delivery carriers. In: Wise D. editor. Handbook of Pharmaceutical Controlled Release Technology. 1st edition. New York: Marcel Dekker. pp 99-130.
20. Vert M. 1998. Bioresorbable synthetic polymers and their operation field. In: Walenkamp G, editor. Biomaterials in surgery. 1st edition. Stuttgart: Georg Thieme Verlag. pp 97-101.
21. Stack RS, Califf R, Phillips HR. 1988. The Duke interventional cardiac catheterization program. J Am Coll Cardiol 62:F3-F4.
22. Gammon RS, Chapman GD, Agrawal G, Bauman RP, Phillips HR, Stack RS. 1991. Mechanical features of the Duke biodegradable intravascular stent. J Am Coll Cardiol 17:235A.
23. Tanguay JF, Zidar JP, Phillips HR, Stack RS. 1994. Current status of biodegradable stents. Cardiol Clin 12:699-713.
24. Susawa T, Shiraki K, Shimizu Y. 1993. Biodegradable intracoranary stents in adult dogs. J Am Coll Cardiol 21:483A.
25. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H. 2000. Initial and 6-month results of biodegradable poly-1-lactic acid coronary stents in humans. Circulation 102:399-404.
26. Yamawaki T, Shimokawa H, Kozai T, Miyata K, Higo T, Tanaka E, Egashira K, Shiraishi T, Tamai H, Igaki K, Takeshita A. 1998. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. J Am Coll Cardiol 32:780-786.
27. Tamai H, Igaki K, Tsuji T, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Motohara S, Uehata H, Takeushi E. 1999. A biodegradable polyl-lactic coronary stent in the porcine coronary artery. J Intervent Cardiol 1999:443-450.
28. Su SH, Chao RY, Landau CL, Nelson KD, Timmons RB, Meidell RS, Eberhart RC. 2003. Expandable bioresorbable endovascular stent. I. Fabrication and properties. Ann Biomed Eng 31:667-677.
29. Venkatraman S, Poh TL, Vinalia T, Mak KH, Boey F. 2003. Collapse pressures of biodegradable stents. Biomaterials 24:2105-2111.
30. Hietala EM, Salminen US, Stahls A, Valimaa T, Maasilta P, Tormala P, Nieminen MS, Harjula ALJ. 2001. Biodegradation of the copolymeric polylactide stent - long-term follow-up in a rabbit aorta model. J Vasc Res 38:361-369.
31. Nuutinen JP, Valimaa T, Clerc C, Tormala P. 2002. Mechanical properties and in vitro degradation of bioresorbable knitted stents. J Biomater Sci Polym Ed 13:1313-1323.
32. Valimaa T, Laaksovirta S, Tammela TLJ, Laippala P, Talja M, Isotalo T, Petas A, Tarri K, Tormala P. 2002. Viscoelastic memory and self-expansion of self-reinforced bioabsorbable stents. Biomaterials 23:3575-3582.
33. Lafont A, Li S, Garreau H, Cornhill F, Vert M. 2006. PLA stereocopolymers as sources of bioresorbable stents: Preliminary investigation in rabbit. J Biomed Mater Res B Appl Biomater 77:349-356.
34. Grizzi I, Garreau H, Li S, Vert M. 1995. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials 16:305-311.
35. Unverdoben M, Spielberger A, Schywalsky M, Labahn D, Hartwig S, Schneider M, Lootz D, Behrend D, Schmitz K, Degenhardt R, Schaldach M, Vallbracht C. 2002. A polyhydroxybutyrate biodegradable stent: Preliminary experience in the rabbit. Cardiovasc Intervent Radiol 25:127-132.
36. Zetlinger J, Schmid E, Brandom D, Bolikal D, Pesnell A, Kohn J. 2004. Advances in the development of coronary stents. Biomater Forum 26:8-9.
37. Tangpasuthadol V, Pendharkar SM, Kohn J. 2000. Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part I: Study of model compounds. Biomaterials 21:2371-2378.
38. Tangpasuthadol V, Pendharkar SM, Peterson RC, Kohn J. 2000. Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part II: 3-yr study of polymeric devices. Biomaterials 21:2379-2387.
39. Brasselet C, Addad F, Lemarchand P, Lafont A. 1999. Local treatment during angioplasty. Archives des Maladies du Coeur et des Vaisseaux 92:1699-1706.
40. Chorny M, Fishbein I, Golomb G. 2000. Drug delivery Systems for the treatment of restenosis. Crit Rev Ther Drug Carrier Syst 17:249-284.
41. Sharkawi T, Leyni Barbaz D, Chikh N, McMullen JN. 2005. Evaluation of the in vitro drug release from resorbable biocompatible coatings for vascular stents. J Bioactive Compatible Polym 20:153-168.
42. Grube E. 2003. Is it the drug? Is it the design? Is it the material? http://www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&_pageLabel= TCTMDContent&hdCon=878197.
43. Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T, Nakamura T, Fujita S, Takeda S, Motohara S, Uehata H. 2003. Biodegradable stents as a platform to drug loading. Int J Cardiovasc Intervent 5:13-16.
44. Ye YW, Landau C, Willard JE, Rajasubramanian G, Moskowitz A, Aziz S, Meideil RS, Eberhart RC. 1998. Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall. Ann Biomed Eng 26:398-408.
45. Zilberman M, Schwade ND, Eberhart RC. 2004. Protein-loaded bioresorbable fibers and expandable stents: Mechanical properties and protein release. J Biomed Mater Res B Appl Biomater 69:1-10.
46. Alexis F, Venkatraman SS, Rath SK, Boey F. 2004. In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices. J Control Release 98:67-74.
47. Vert M, Mauduit J, Li SM. 1994. Biodegradation of PLA/GA polymers: Increasing complexity. Biomaterials 15:1209-1213.
48. Schwach G, Engel R, Coudane J, Vert M. 1994. Stannous octoate versus zinc-initiated polymerization of racemic lactide: Effect of configurational structures. Polym Bull 32:617-623.
49. Venkatraman S, Tan LP, Joso JFD, Boey F, Wang X. 2006. Biodegradable stents with elastic memory. Biomaterials 27:1573-1578.
50. Meyer Elbaz EEM, Joelle Fourcade, Sami Mourali, Robert Hobeika, Didier Carrié, Jacques Puel, 2002. Does stent design affect the long-term outcome after coronary stenting? Catheter Cardiovasc Interv 56:305-311.
51. Schwartz RS, Edelman ER. 2002. Drug-eluting stents in preclinical studies, recommended evaluation from a consensus group. Circulation 106:1867-1873.